$4.02 $0.00 (0.0%)

04:30 PM EDT on 07/10/20

Opko Health, Inc. (NASDAQ:OPK)

CAPS Rating: 3 out of 5

Current Price $4.02 Mkt Cap $2.7B
Open $3.96 P/E Ratio 0.00
Prev. Close $4.02 Div. (Yield) $0.00 (0.0%)
Daily Range $3.91 - $4.14 Volume 9,560,052
52-Wk Range $1.12 - $4.27 Avg. Daily Vol. 14,389,348

Caps

How do you think NASDAQ:OPK will perform against the market?

Add Stock to CAPS Watchlist

All Players

241 Outperform
28 Underperform
 

All-Star Players

12 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:OPK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TheBigFinn (< 20)
Submitted October 04, 2015

Their 4KScore Test accurately predicts prostate cancer risk has received insurance classificationTheir drug Rayaldee with a +$10B market potential completed phase 3 trials and an NDA was submitted to to the FDA last May we approval expect in… More

allstar31 (99.95)
Submitted September 13, 2014

Uses known stock promoter Redchip.com. Is a pump and dump scam.

Recent Community Commentary

Read the most recent pitches from players about OPK.

Recs

0
Member Avatar Paco57 (61.97) Submitted: 7/6/2020 7:18:09 PM : Outperform Start Price: $3.69 NASDAQ:OPK Score: +8.19

Looking pretty Good!

Recs

0
Member Avatar TMFSaintCroix (99.80) Submitted: 3/6/2020 4:29:10 PM : Outperform Start Price: $2.40 NASDAQ:OPK Score: +58.32

I'm buying Opko Health as part of a Covid-19 basket. My other two stocks in this area are Novavax and Altimmune. Opko is one of the largest diagnostic companies in the US, and they are introducing a diagnostic test for Covid-19 next week. Unlike Novavax and Altimmune, who are biotechs doing research into vaccines for Covid-19 (and the flu), Opko's diagnostic will be approved right away, and they can start getting revenues very quickly. Congress just approved $8.3 billion in emergency spending for Covid-19, so I assume some of that money will be heading Opko's way. Outperform.

Recs

0
Member Avatar TMFBiologyFool (71.12) Submitted: 7/12/2018 5:30:48 PM : Underperform Start Price: $6.23 NASDAQ:OPK Score: +49.32

Up substantially on no apparent news.

Leaderboard

Find the members with the highest scoring picks in OPK.

Score Leader

romanson3625

romanson3625 (< 20) Score: +236.00

The Score Leader is the player with the highest score across all their picks in OPK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stereotyp72 64.90 11/5/2019 Outperform 5Y $1.52 +164.47% +3.33% +161.14 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. superdealsonly 35.45 2/4/2013 Underperform 5Y $6.81 -40.97% +111.43% +152.40 0 Comment
MisterCHW 99.88 1/29/2013 Underperform 5Y $6.80 -40.88% +111.09% +151.97 0 Comment
iniesta13 < 20 3/25/2013 Underperform 1Y $7.61 -47.17% +103.72% +150.89 0 Comment
tortoisetriguy 42.01 2/14/2013 Underperform 5Y $6.83 -41.14% +109.52% +150.66 0 Comment
XMFConnor 94.38 5/16/2012 Underperform 5Y $4.62 -12.99% +137.29% +150.27 0 Comment
Covestor 75.68 3/14/2011 Underperform NS $3.76 +6.91% +144.95% +138.03 1 Comment
Quaker08 24.19 12/12/2013 Underperform 5Y $9.74 -58.71% +78.41% +137.12 0 Comment
stratisticalarb 59.59 4/26/2011 Underperform 1Y $3.99 +0.74% +135.84% +135.10 0 Comment
eagles777 65.18 4/16/2020 7/6/2020 Outperform NS $1.64 +145.87% +13.97% +131.90 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for OPK.